PlainRecalls
FDA Devices Moderate Class II Ongoing

Randox RX Series Urea Enzymatic Kinetic Assay Ref. Numbers: (1) UR3825 (2) UR3873 (3) UR8334 (4) UR8070 (Modena)

Reported: August 16, 2023 Initiated: June 13, 2023 #Z-2362-2023

Product Description

Randox RX Series Urea Enzymatic Kinetic Assay Ref. Numbers: (1) UR3825 (2) UR3873 (3) UR8334 (4) UR8070 (Modena)

Reason for Recall

Carryover from the Direct LDL-cholesterol assay on the Rx instruments may result in a negative bias, up to -11%, in quality control and patient samples, in urea assays results if the urea assay is run immediately after the Direct LDL-cholesterol assay. This may lead to a delay in reporting results or in falsely decreased urea test results.

Details

Recalling Firm
Randox Laboratories Ltd.
Units Affected
37 US 194 PR
Distribution
US Nationwide distribution in the states of CA, DC, GA, OH, OK, MN, MO, NJ, VA and Puerto Rico.
Location
Crumlin (North), N/A

Frequently Asked Questions

What product was recalled?
Randox RX Series Urea Enzymatic Kinetic Assay Ref. Numbers: (1) UR3825 (2) UR3873 (3) UR8334 (4) UR8070 (Modena). Recalled by Randox Laboratories Ltd.. Units affected: 37 US 194 PR.
Why was this product recalled?
Carryover from the Direct LDL-cholesterol assay on the Rx instruments may result in a negative bias, up to -11%, in quality control and patient samples, in urea assays results if the urea assay is run immediately after the Direct LDL-cholesterol assay. This may lead to a delay in reporting results or in falsely decreased urea test results.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 16, 2023. Severity: Moderate. Recall number: Z-2362-2023.